"Helius Medical Technologies, Inc. Receives HCPCS Codes for PoNS® Mouthpiece and Controller"
Originally Published 1 year ago — by GlobeNewswire
Helius Medical Technologies, Inc. has obtained HCPCS Level II codes for its Portable Neuromodulation Stimulator (PoNS) mouthpiece and controller, a significant step towards reimbursement for the only U.S.-approved medical device for treating gait deficit due to multiple sclerosis. The company's recent stock issuances have extended its cash runway into the third quarter of 2024. The PoNS device, indicated for use in the U.S. as a short-term treatment for gait deficit due to mild-to-moderate MS symptoms, is also being pursued for stroke authorization.